Copyright
©The Author(s) 2016.
World J Hepatol. Feb 18, 2016; 8(5): 301-306
Published online Feb 18, 2016. doi: 10.4254/wjh.v8.i5.301
Published online Feb 18, 2016. doi: 10.4254/wjh.v8.i5.301
Table 3 White blood cell DNA methylation and hepatocellular carcinoma risk
| Locus | Cases/controls | OR (95%CI) | |
| WNK2 cg10272601 | Below median (< 0.279) | 56/157 | 1.0 |
| Above median (≥ 0.279) | 103/155 | 1.91 (1.27-2.86) | |
| TPO cg12680131 | Below median (< 0.836) | 102/157 | 1.0 |
| Above median (≥ 0.836) | 57/155 | 0.59 (0.39-0.87) | |
| MYT1L cg22511877 | Below median (< 0.636) | 105/159 | 1.0 |
| Above median (≥ 0.636) | 54/153 | 0.50 (0.33-0.77) |
- Citation: Wu HC, Shen J, Yang HI, Tsai WY, Chen CJ, Santella RM. Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan. World J Hepatol 2016; 8(5): 301-306
- URL: https://www.wjgnet.com/1948-5182/full/v8/i5/301.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i5.301